Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
27.70
+2.21 (8.67%)
At close: Dec 5, 2025, 4:00 PM EST
27.60
-0.10 (-0.36%)
After-hours: Dec 5, 2025, 7:59 PM EST
Moderna Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Moderna stock have an average target of 33.91, with a low estimate of 18 and a high estimate of 63. The average target predicts an increase of 22.42% from the current stock price of 27.70.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 13 | 12 | 12 | 8 | 8 | 8 |
| Sell | 3 | 4 | 4 | 4 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 19 | 15 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $69 → $63 | Buy | Reiterates | $69 → $63 | +127.44% | Nov 21, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $28 → $25 | Hold | Maintains | $28 → $25 | -9.75% | Nov 21, 2025 |
| Leerink Partners | Leerink Partners | Sell Maintains $15 → $18 | Sell | Maintains | $15 → $18 | -35.02% | Nov 21, 2025 |
| Barclays | Barclays | Hold Maintains $31 → $25 | Hold | Maintains | $31 → $25 | -9.75% | Nov 7, 2025 |
| UBS | UBS | Strong Buy Maintains $70 → $40 | Strong Buy | Maintains | $70 → $40 | +44.40% | Oct 23, 2025 |
Financial Forecast
Revenue This Year
1.94B
from 3.24B
Decreased by -40.17%
Revenue Next Year
1.95B
from 1.94B
Increased by 0.77%
EPS This Year
-8.31
from -9.28
EPS Next Year
-7.23
from -8.31
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.3B | 2.5B | ||||
| Avg | 1.9B | 2.0B | ||||
| Low | 1.7B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -30.2% | 27.0% | ||||
| Avg | -40.2% | 0.8% | ||||
| Low | -47.5% | -31.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -7.84 | -5.53 | ||||
| Avg | -8.31 | -7.23 | ||||
| Low | -9.39 | -8.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.